(Q48496304)

12 February 2018

title

brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. (English)

1 reference

12 February 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

Stefan Krüger

1

1 reference

12 February 2018

Jürgen Graf

2

1 reference

12 February 2018

Dagmar Kunz

3

1 reference

12 February 2018

Tina Stickel

4

1 reference

12 February 2018

Peter Hanrath

5

1 reference

12 February 2018

Uwe Janssens

6

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

12 February 2018

Journal of the American College of Cardiology

published in

1 reference

12 February 2018

volume

40

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

page(s)

718-722

1 reference

12 February 2018

Relationship between exertional symptoms and functional capacity in patients with heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Improvement in exercise capacity of candidates awaiting heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Role of endothelin in the exercise intolerance of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Peak VO(2): a simple yet enduring standard

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

Plasma concentration of human brain natriuretic peptide in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902032-6

7 January 2021

10.1016/S0735-1097(02)02032-6

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

12204502

1 reference

12 February 2018